India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.
The Financial Express50m
Q3FY25: GSK pharma’s profit surges 4X to Rs 229 crore; Revenue up 18 percent
In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...
News Medical on MSN19h
Clear Communication and Decision-Making Tools Boost Vaccination Rates in Older Adults
A clear endorsement from their healthcare provider and being supplied information about recommended vaccines before their ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...
Music Business Worldwide22h
BMG rebrands as part of its ‘BMG Next’ strategy – with new symbol, color scheme, and redesigned website
BMG has introduced a new brand identity, including a new symbol, updated color scheme, and redesigned website. According to ...
Business Standard21h
Glaxosmithkline Pharmaceuticals Share Price
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc. a global biopharma company to unite science technology and talent to get ahead of disease together. The Company is ...